Targeted proteomics improves cardiovascular risk prediction in secondary prevention
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted proteomics improves cardiovascular risk prediction in secondary prevention
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-01-29
DOI
10.1093/eurheartj/ehac055
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting inflammation in atherosclerosis — from experimental insights to the clinic
- (2021) Oliver Soehnlein et al. NATURE REVIEWS DRUG DISCOVERY
- Coronary Artery Disease Genetics Enlightened by Genome-Wide Association Studies
- (2021) Thorsten Kessler et al. JACC-Basic to Translational Science
- Calculating the sample size required for developing a clinical prediction model
- (2020) Richard D Riley et al. BMJ-British Medical Journal
- Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy
- (2020) Tjerk S.J. Opstal et al. CIRCULATION
- Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention
- (2020) Renate M Hoogeveen et al. EUROPEAN HEART JOURNAL
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma protein patterns as comprehensive indicators of health
- (2019) Stephen A. Williams et al. NATURE MEDICINE
- Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function
- (2018) Yasuaki Aratani ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Statin Trials, Cardiovascular Events, and Coronary Artery Calcification
- (2018) Martin Bødtker Mortensen et al. JACC-Cardiovascular Imaging
- Associations of Circulating Protein Levels With Lipid Fractions in the General Population
- (2018) Sylwia M. Figarska et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk
- (2018) Paul M Ridker JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease
- (2018) Michiel J. Bom et al. EBioMedicine
- ‘Highest risk–highest benefit’ strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies
- (2017) Lieven Annemans et al. EUROPEAN HEART JOURNAL
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk Prediction
- (2016) Jesper K. Jensen CIRCULATION
- Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationClinical Perspective
- (2016) Lotte Kaasenbrood et al. CIRCULATION
- Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin
- (2016) Paul M Ridker EUROPEAN HEART JOURNAL
- Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease
- (2016) Peter Ganz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transformative Impact of Proteomics on Cardiovascular Health and Disease
- (2015) Merry L. Lindsey et al. CIRCULATION
- Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction
- (2015) Dimitrios A. Stakos et al. EUROPEAN HEART JOURNAL
- Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective
- (2015) Tomas Jernberg et al. EUROPEAN HEART JOURNAL
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A1M/α1-microglobulin is proteolytically activated by myeloperoxidase, binds its heme group and inhibits low density lipoprotein oxidation
- (2015) Martin Cederlund et al. Frontiers in Physiology
- Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100
- (2014) Cédric Delporte et al. JOURNAL OF LIPID RESEARCH
- Matrix Metalloproteinase 7 Is Associated with Symptomatic Lesions and Adverse Events in Patients with Carotid Atherosclerosis
- (2014) Azhar Abbas et al. PLoS One
- Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score
- (2013) Johannes A N Dorresteijn et al. HEART
- Interpreting Incremental Value of Markers Added to Risk Prediction Models
- (2012) Michael J. Pencina et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects
- (2011) Ian Toma et al. CELL AND TISSUE RESEARCH
- GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice
- (2011) Tibor Kempf et al. NATURE MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now